US Surgical acquires vascular repair technology:
This article was originally published in Clinica
US Surgical and EndoTex Interventional Systems have agreed to collaborate on the development of vascular repair technologies for aortic aneurysms and AV fistulas. The companies plan to begin clinical trials of EndoTex' stent graft for abdominal aortic aneurysm repair later this year. The agreement gives US Surgical the right to acquire the stent grafts and delivery systems, which can be used for iliac, femoral and thoracic aneurysm repair. Around 300,000 patients suffer an aneurysm every year in the US but only a small percentage of cases can be treated surgically.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the vision. That is the thrust of EY’s NextWave Report: New Horizons 2019. Additionally, for medtechs seeking business continuum, “duality” is now a preoccupying thought.
The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure of responsible business behavior in the coming decade. Uncertainty about the extent of these commitments – commonly referenced as the environmental, social and governance (ESG) agenda – has produced equally variable responses from companies in the health care business.